NASDAQ : BBIO

BridgeBio Pharma, Inc. — Stock Grades

$84.02 USD

$1.09 (1.31%)

Volume
2.03M
Average Volume
3.65M
Market Capitalization
$16.46B
P/E Ratio
-22.41
Dividend Yield
0.00%
Price Target
$100.00
Year High
$93.42
Year Low
$42.09
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.44
BBIO Stock Grades
Date Grading Company Previous Grade New Grade Action
2026-07-16 Citigroup Neutral Neutral Maintain
2026-07-13 HC Wainwright & Co. Buy Buy Maintain
2026-06-16 Mizuho Outperform Outperform Maintain
2026-05-28 HC Wainwright & Co. Buy Buy Maintain
2026-05-28 Morgan Stanley Overweight Overweight Maintain
2026-05-26 Raymond James Outperform Market Perform Downgrade
2026-05-11 HC Wainwright & Co. Buy Buy Maintain
2026-05-08 Evercore ISI Group Outperform Outperform Maintain
2026-04-29 HC Wainwright & Co. Buy Buy Maintain
2026-04-29 Truist Securities Buy Buy Maintain
2026-04-28 Mizuho Outperform Outperform Maintain
2026-04-27 HC Wainwright & Co. Buy Buy Maintain
2026-03-18 Mizuho Outperform Outperform Maintain
2026-03-10 JP Morgan Overweight Overweight Maintain
2026-02-25 Oppenheimer Outperform Outperform Maintain
2026-02-25 Morgan Stanley Overweight Overweight Maintain
2026-02-25 Truist Securities Buy Buy Maintain
2026-02-25 Evercore ISI Group Outperform Outperform Maintain
2026-02-17 HC Wainwright & Co. Buy Buy Maintain
2026-02-13 Wells Fargo Overweight Overweight Maintain
2026-02-13 Oppenheimer Outperform Outperform Maintain
2026-01-20 Wells Fargo Overweight Overweight Maintain
2026-01-08 Truist Securities Buy Buy Maintain